HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

So far this year, Eli Lilly (NYSE: LLY) has been on an absolute tear and is swiftly becoming the world's most prolific ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic ... [20] Nurse practitioner: A ...

Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions, set ...

A Lancet study suggests that popular weight loss drugs could lead to muscle loss. Reserachers recommend combining these ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

To mark this year’s Pro Bono Week, which concludes today, the CEO’s of the UK’s three main pro bono charities – A4ID, ...

Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists ...